ArticleJournal of pharmaceutical policy and practice2026
Stakeholders' views on the development and adoption of health policies related to pharmacist scope of practice and the pharmacy practice environment in Australia.
Article in Journal of pharmaceutical policy and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Translating research on Pharmacy Practice Environments and Pharmacists' Scope of Practice (PPEAPSOP) into actionable policy requires a comprehensive understanding of policy components, underpinning processes, and identifying barriers and enablers influencing policy formulation and adoption. This research examined the influences on the development and adoption of PPEAPSOP policies and whether frameworks, theories or models (FTMs) are employed to support these processes. Method: Three focus groups and ten semi-structured interviews were conducted, adopting a qualitative design between May and September 2025. Participants were identified using the RISA tool and included pharmacists, medical practitioners, organisational, government and consumer representatives. Focus groups and interviews were recorded, transcribed and deductively thematically analysed using NVivo and a 16-item checklist. Results: Twenty-six participants participated in focus groups ( Conclusions: The development and adoption of PPEAPSOP policies depend on alignment amongst policy actors, navigation of systemic constraints, strategic foresight of policy implications, and a narrative grounded in robust evidence, =contextualised to the policy environment. Current approaches to the development and adoption of PPEAPSOP policies highlight gaps, underscoring the need for a flexible framework for policymakers and decision makers to strengthen and accelerate policy outcomes. Exploration of a framework may align key components and support more coherent, evidence-informed approaches to targeted policy development and adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.